June 6, 2011 (Washington, DC) — A post hoc analysis of a phase 3 clinical trial of the acute migraine drug dihydroergotamine (Levadex, MAP Pharmaceuticals Inc) using 4 different previously published ...
To determine whether a variable definition of biochemical recurrence (BCR) based on clincopathologic features facilitates early identification of patients likely to suffer from disease progression.
Active Surveillance Cost-Effective for Prostate Cancer Study finds longest time to recurrence 15.5 years, with containment up to 25 years of follow-up For men with prostate cancer, treatment with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback